Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

KVUE

+ Watchlist+ Portfolio

Kenvue Inc.

Regulated industryPhysical productsConsumer brandTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$19.56
52-Week Range
$15.94 – $20.13
Market Cap
$37.11B
P/E (TTM)
21.94
EPS (TTM)
0.88
Dividend Yield
4.35%
Advanced Metrics
Price/Book
3.65
PEG Ratio
1.53
Return on Equity
16.25%
Return on Assets
7.03%
Gross Margin
58.53%
Operating Margin
19.22%
Profit Margin
10.88%
Current Ratio
0.95
Debt/Equity
0.82
Total Debt
$8.34B
Free Cash Flow
$2.77B
Revenue Growth
3.20%
Earnings Growth
6.00%
Enterprise Value
$44.41B

Market Snapshot

About

Kenvue Inc. is a consumer health company formed through Johnson & Johnson's spin-off of its consumer health business. The company owns a portfolio of well-known brands including Tylenol, Listerine, Johnson's Baby, Band-Aid, Neutrogena, and Aveeno. Kenvue focuses on self-care products across skin health and beauty, essential health, and personal care categories, serving consumers in more than 100 countries worldwide.